ICAO · Registering as Listener

International Conference on Advances in Oncology

20th Feb – 21st Feb 2027 Nagoya, Japan Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICAO
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Advances in Oncology conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities

This track focuses on the latest advancements in cancer research methodologies and technologies. Participants will explore novel approaches to understanding tumor biology and the underlying mechanisms of cancer progression.

This session highlights recent breakthroughs in clinical oncology practices and patient management. Discussions will center around evidence-based treatments and the integration of new therapies into standard care.

This track delves into the intricate relationship between tumor biology and the surrounding microenvironment. Researchers will present findings on how these interactions influence cancer development and treatment responses.

This session aims to discuss innovative strategies for cancer prevention and early detection. Emphasis will be placed on lifestyle modifications, screening programs, and public health initiatives.

This track explores the role of precision medicine in tailoring cancer treatment to individual patient profiles. Participants will examine genomic profiling, biomarkers, and personalized therapeutic approaches.

This session focuses on the translation of laboratory findings into clinical applications in oncology. Discussions will highlight successful case studies and the challenges faced in implementing research into practice.

This track addresses the rapidly evolving field of immuno-oncology and its impact on cancer treatment. Experts will share insights on novel immunotherapeutic agents and their mechanisms of action.

This session will cover the latest emerging therapies in the treatment of various cancers. Participants will discuss clinical trial results and the potential of these therapies to improve patient outcomes.

This track focuses on the unique challenges faced in the field of pediatric oncology. Experts will discuss advancements in treatment protocols and the importance of addressing the psychosocial aspects of care.

This session aims to explore the disparities in cancer care and outcomes among different populations. Discussions will focus on strategies to improve access to care and address social determinants of health.

This track will provide a platform for discussing future research directions in oncology. Participants will explore emerging technologies, novel therapeutic targets, and the potential impact on cancer care.

COPYRIGHT © 2026 International Conference on Advances in Oncology. ALL RIGHTS RESERVED